IFP Advisors’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IFP Advisors's ONCY Position: Q3 2026 in Review
IFP Advisors opened a new position in Oncolytics Biotech (ONCY) in Q3 2026: 350 shares worth $234. The stake represents ﹤0.01% of the portfolio and ranks #4839 among its holdings. This is a return to the name: IFP Advisors previously reported a position in ONCY as recently as Q3 2025.
IFP Advisors first reported a position in ONCY in Q4 2019 and has held it in 21 quarters since. The position peaked at $19K in Q1 2021. 12 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.
- IFP Advisors held 350 shares of Oncolytics Biotech worth $234 as of Q3 2026.
- Oncolytics Biotech was a new IFP Advisors position in Q3 2026.
- Oncolytics Biotech made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4839 holding.
- IFP Advisors first reported a position in Oncolytics Biotech in Q4 2019 and has held it in 21 quarters since.
- IFP Advisors's Oncolytics Biotech position peaked at $19K in Q1 2021.
- 12 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.